Intranasal human growth hormone (hGH) induces IGF-I levels comparable to subcutaneous injection with lower systemic exposure to hGH in healthy volunteers.
AffiliationCritical Pharmaceuticals Limited, BioCity Nottingham, Pennyfoot St, Nottingham
MetadataShow full item record
AbstractThe development of an improved, efficacious hGH product administered by a non-injectable route of delivery such as the nasal route is highly desirable. We have developed a novel nasal hGH product (CP024) that showed excellent nasal absorption in animal models, however translation of these results into the clinical setting is essential, as past attempts to develop such formulations by other groups have been unable to induce IGF-1 in man.
CitationIntranasal human growth hormone (hGH) induces IGF-I levels comparable to subcutaneous injection with lower systemic exposure to hGH in healthy volunteers. 2015:jc20144146 J Clin Endocrinol Metab
JournalJournal of Clinical Endocrinology and Metabolism